跳至主要内容
临床试验/ACTRN12614000684628
ACTRN12614000684628已完成未知

Effectiveness of feedback control on neural stimulation in patients with chronic pain with regard to pain relief and stimulation side effects in an extended trial

Saluda Medical Pty Ltd0 个研究点目标入组 25 人开始时间: 2014年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • •Patients enrolled in this study must meet the following inclusion criteria:
  • •1.Have been diagnosed with chronic, intractable pain, which has been refractory to conservative therapy for a minimum of 3 months.
  • •2.Have been approved to undergo a trial of neural stimulation. Neural stimulation can include spinal cord stimulation (cervical, thoracic or sacral), peripheral nerve stimulation (such as occipital or sacral nerves), dorsal root, or dorsal root ganglion.
  • •3.Be an appropriate candidate for the surgical procedures required in this study based on the clinical judgment of the implanting physician
  • •4.Be on a stable dose (no new, discontinued, or changes in dose) of all prescribed pain medication for at least 4 weeks prior to the trial
  • •5.Be 18 years of age or older at the time of enrolment
  • •6.Be willing and capable of giving written informed consent
  • •7.Be willing and able to comply with study-related requirements, procedures, and visits.

排除标准

  • •Patients enrolled in this study must not meet the following exclusion criteria:
  • •1.Have a medical condition or pain in area(s) that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints, as determined by the Investigator
  • •2.Have evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcomes
  • •3.Have a current diagnosis of a coagulation disorder, bleeding diathesis, progressive peripheral vascular disease or uncontrolled diabetes mellitus
  • •4.Have a diagnosis of scoliosis that precludes lead placement in epidural space (for SCS patients only)
  • •5.Have an existing drug pump and/or neural stimulation system or another active implantable device such as a pacemaker
  • •6.Have a condition currently requiring or likely to require the use of MRI or diathermy
  • •7.Have pain due to a malignant disease
  • •8.Have a life expectancy of less than 1 year
  • •9.Have an active systemic or local infection
  • •10.Be allergic, or have shown hypersensitivity, to any materials of the neurostimulation system which come in contact with the body
  • •11.Be pregnant or nursing (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile or be at least 2 years post-menopausal)
  • •12.Have within 6 months of enrolment a significant untreated addiction to dependency producing medications or have been a substance abuser (including alcohol and/or illicit drugs)
  • •13.Be concomitantly participating in another clinical study
  • •14.Be involved in an injury claim under current litigation

研究者

发起方
Saluda Medical Pty Ltd

相似试验